50 results
6-K
EX-99.1
CNTG
Centogene NV
29 Feb 24
Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected
5:00pm
, Senior Director Genomic Innovation at CENTOGENE, added, “Until now, the impact of pre-TCRα deficiency has been largely unknown. By leveraging our … -institutional collaboration can achieve,” added Christian Ganoza, Senior Scientist Genomic Innovation at CENTOGENE. “By partnering with Dr. Vivien Béziat
6-K
EX-99.1
CNTG
Centogene NV
25 Jan 24
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
6:30am
in a single location to work with patients, with the ambition of accelerating research and diagnosis and therapeutic innovation to change the lives
6-K
EX-99.3
CNTG
Centogene NV
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
, dated as of October 26, 2023, between Lender, DPE Deutsche Private Equity GmbH, Careventures Fund II S.C.Sp, and TVM Life Science Innovation I, L.P … Private Equity GmbH, (b), Careventures Fund II S.C.Sp, and (c) TVM Life Science Innovation I, L.P.
“Subsidiary” means, with respect to any Person
6-K
EX-99.2
CNTG
Centogene NV
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
the Lender, DPE Deutsche Private Equity GmbH, Careventures Fund II S.C.Sp, and TVM Life Science Innovation I, L.P., as the same may be amended … a Fundamental Change if (i) DPE Deutsche Private Equity GmbH, (ii) Careventures Fund II S.C.Sp and (iii) TVM Life Science Innovation I, L.P
6-K
EX-99.6
CNTG
Centogene NV
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
II S.C.Sp, a special limited partnership organized under the laws of Luxembourg (“Careventures”), TVM Life Science Innovation I, L.P., a Canadian … limited partnership organized under the laws of Quebec (“TVM I”) and TVM Life Science Innovation II SCSp, a special limited partnership organized under
6-K
EX-99.1
idh0gmv 0zl9fmjx7o
27 Oct 23
Variation Agreement to Joint Venture Agreement
7:28am
6-K
i2nwn0be
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.6
n0zyz
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.3
t8uv blyln1ol
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.2
07j5nnc 8tueuurhivs
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.4
1fmml
27 Jun 23
Current report (foreign)
9:36am
6-K
EX-99.1
v7h0o
26 Apr 23
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
8:16am
6-K
EX-99.2
thxun7i4r0ro7
15 Jul 22
CENTOGENE Reports First Quarter 2022 Financial Results
9:37am
6-K
EX-99.1
p8luoqueo7282e2s
30 Mar 22
CENTOGENE Reports Fourth Quarter and Fiscal Year 2021 Financial Results
7:54am
6-K
EX-99.1
igjzyme
8 Feb 22
CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO
6:34am
6-K
EX-99.1
ummenriprfuy1cyx3od
3 Feb 22
Current report (foreign)
6:03am
6-K
EX-99.5
6ayriu 99k2e
1 Feb 22
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
9:30am
6-K
EX-99.1
1uabfd1k3 g370
1 Feb 22
CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan
9:30am